Target Price .09 to 2.1, page-13

Steve2488 - if you have a look back at announcements from Dec 2013 he features quite prominently. He is founder & CEO of Invatec; on 14/4/13 acquires breakthrough diagnostic tool for mental illness & 'worldwide' license to the suite of 3 patents NZ/AU/israel (it's a small world after all).
29/4/13 announcement Mr Solitario appointed executive director of bpo on 250K for the pleasure with Mr Stephen Stapelberg as Commercial Development manager.
12/5/14 Shareholder letter announcement he said validation trials would be undertaken in less than 6 months- no news yet but it must be close; 18/6/14 announcement (exciting) he was responding to an explosive(!) demand for E-health with lots of talk about a smart phone app & plans to commercialise in USA;
1/10/14 brings us to capital raising presentation (?tizzied up version of December's) with TWELVE different target markets (count them 12).......Announced in Sep he is no longer exec director of bpo (i think that job is now Kris Knauer geologist) but Mr Solitario was named one of the "Executives" in aforementioned prez- together with Dr Mesnik US based physician & Stephen Stapelberg. Additionally Claude Solitario & Stephen Stapelberg are 1-2 on the baillieu holst report under "leadership". You would think I would have something better to do than peruse bpo announcements but wouldn't investors like to know there is some authenticity behind all the chaotic marketing/advertising speak, & integrity/transparency/continuity etc etc... Angrytan says there has never been a PRODUCT come to fruition with this company which is worrying & I find it interesting that every person (other than Mr Solitario that is) on the executive or bpo board plus the new medical advisory board can clearly state their qualifications & where they have worked/are currently working....